Tesla delivered a solid batch of vehicles in the second quarter, but the real test for the stock comes on July 22, when the company reports earnings. According to analysts at Morgan Stanley, the market's attention is shifting away from near-term car sales and toward proof that Tesla's next-generation products—robotaxis and the Optimus humanoid robot—are advancing fast enough to justify a rapidly rising bill for artificial intelligence and manufacturing.
What's happening with Tesla's numbers
Tesla's Q2 delivery figures came in stronger than many expected, helped by factors like higher gas prices and easier year-over-year comparisons in Europe. The company's energy storage business also showed momentum. But Morgan Stanley, a global investment bank, argues that these positives are now largely priced in. The bank maintained an equal-weight rating on Tesla shares and nudged its price target to $417 from $415, with the stock trading around $397.97 at the time of its note.
The bigger story is on the spending side. Morgan Stanley notes that capital expenditures—money spent on factories, equipment, and new technology—are on track to double this year. At the same time, free cash flow, which is the cash left after paying operating costs and investment spending, has turned negative. When a company burns cash while investing heavily, investors typically demand clearer, checkable milestones to justify the valuation.
Why robotaxis and Optimus matter now
Morgan Stanley said the July 22 earnings call will hinge on three specific areas: where robotaxis could expand, whether the Optimus Gen 3 robot is validated and ready to ramp up production, and how close the so-called “cybercab” manufacturing is to being production-ready. These aren't just side projects—they represent the core of Tesla's long-term valuation thesis.
For everyday investors, the shift is important because it changes how the stock behaves. If Tesla is funding a bigger AI and robotics buildout, the stock's valuation tends to act less like a carmaker's and more like a long-term bet on execution. That makes the July 22 update unusually sensitive to specifics: named robotaxi rollout locations and timelines, evidence that Optimus Gen 3 can work reliably outside the lab, and signs that cybercab production is more than a concept. Clear milestones can reduce perceived execution risk and support a higher valuation multiple; vague progress usually does the opposite, even if deliveries look fine.
This dynamic is similar to what other companies face when they pivot toward AI-heavy strategies. For example, Keysight Technologies has been highlighted as an unsung AI infrastructure play, while UBS noted that Solstice's Element deal shifts focus to AI, nuclear, and data centers, underscoring how capital-intensive AI investments are reshaping valuations across sectors.
What it means for investors
For those holding Tesla shares or watching from the sidelines, the key takeaway is that the July 22 earnings call is less about how many cars Tesla sold last quarter and more about whether the company can show tangible progress on its most ambitious projects. The doubling of capex and negative free cash flow mean that Tesla is essentially betting the house on autonomy and robotics. If management can point to specific milestones—like a confirmed robotaxi launch city or a factory line for cybercabs—the stock could get a boost. If the update is vague, the market may punish the stock despite decent delivery numbers.
Morgan Stanley's equal-weight rating suggests the bank sees the stock as fairly valued at current levels, but the price target implies modest upside. The real swing factor is execution on the AI and robotics front. Investors should listen closely for concrete details on July 22, because in a world where data center operators are eyeing billion-dollar IPOs and biotech firms are pivoting to nuclear, the market is rewarding companies that can show they're serious about scaling new technologies.
In short, Tesla's Q2 delivery strength is a nice headline, but the July 22 earnings call will determine whether the stock's AI-driven valuation holds up. Keep an eye on robotaxi timelines, Optimus validation, and cybercab production readiness—those are the numbers that will move the stock now.
